株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

深部脳刺激装置:医療機器のパイプライン評価

Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2015

発行 GlobalData 商品コード 347932
出版日 ページ情報 英文 133 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
深部脳刺激装置:医療機器のパイプライン評価 Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2015
出版日: 2015年12月01日 ページ情報: 英文 133 Pages
概要

当レポートでは、深部脳刺激装置のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 深部脳刺激装置の概要

第3章 開発中の製品

  • 深部脳刺激装置 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:地域別
  • 深部脳刺激装置 - パイプライン製品:規制別
  • 深部脳刺激装置 - パイプライン製品:承認予定日別
  • 深部脳刺激装置 - 進行中の臨床試験

第4章 深部脳刺激装置 - 開発中のパイプライン製品:企業別

  • 深部脳刺激装置企業 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:開発段階別

第5章 深部脳刺激装置企業と製品の概要

  • Adaptive Neuromodulation GmbH
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Brainsway Ltd.
  • Cerene Biomedics, Inc
  • Children's Hospital Boston
  • Cleveland Medical Devices, Inc.
  • Clinatec
  • Deep Brain Innovations, LLC
  • Duke University
  • Functional Neuromodulation Inc.
  • Highland Instruments, Inc.
  • Massachusetts General Hospital
  • Mayo Clinic.
  • Medtronic plc
  • National Cheng-Kung University Hospital
  • NeuroPro Technologies, Inc.
  • NeuroSigma, Inc.
  • Nuraleve Inc.
  • Soterix Medical Inc
  • St. Jude Medical, Inc.
  • SUNY Downstate Medical Center
  • The University of Utah
  • University of California, Los Angeles
  • University of Central Florida
  • University of Illinois
  • University of Milan
  • University of Oxford
  • University of South Florida
  • Wedge Therapeutics

第6章 深部脳刺激装置 - 最近の動向

第7章 付録

図表

目次
Product Code: GDME0113EPD

GlobalData's Medical Devices sector report, "Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2015" provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Deep Brain Stimulators Overview

3. Products under Development

  • 3.1. Deep Brain Stimulators - Pipeline Products by Stage of Development
  • 3.2. Deep Brain Stimulators - Pipeline Products by Territory
  • 3.3. Deep Brain Stimulators - Pipeline Products by Regulatory Path
  • 3.4. Deep Brain Stimulators - Pipeline Products by Estimated Approval Date
  • 3.5. Deep Brain Stimulators - Ongoing Clinical Trials

4. Deep Brain Stimulators - Pipeline Products under Development by Companies

  • 4.1. Deep Brain Stimulators Companies - Pipeline Products by Stage of Development
  • 4.2. Deep Brain Stimulators - Pipeline Products by Stage of Development

5. Deep Brain Stimulators Companies and Product Overview

  • 5.1. Adaptive Neuromodulation GmbH Company Overview
    • 5.1.1. Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Aleva Neurotherapeutics SA Company Overview
    • 5.2.1. Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Boston Scientific Corporation Company Overview
    • 5.3.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Brainsway Ltd. Company Overview
    • 5.4.1. Brainsway Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Cerene Biomedics, Inc. Company Overview
    • 5.5.1. Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Children's Hospital Boston Company Overview
    • 5.6.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Cleveland Medical Devices, Inc. Company Overview
    • 5.7.1. Cleveland Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Clinatec Company Overview
    • 5.8.1. Clinatec Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Deep Brain Innovations, LLC Company Overview
    • 5.9.1. Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Duke University Company Overview
    • 5.10.1. Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Functional Neuromodulation Inc. Company Overview
    • 5.11.1. Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Highland Instruments, Inc. Company Overview
    • 5.12.1. Highland Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Massachusetts General Hospital Company Overview
    • 5.13.1. Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Mayo Clinic. Company Overview
    • 5.14.1. Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Medtronic plc Company Overview
    • 5.15.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. National Cheng-Kung University Hospital Company Overview
    • 5.16.1. National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. NeuroPro Technologies, Inc. Company Overview
    • 5.17.1. NeuroPro Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. NeuroSigma, Inc. Company Overview
    • 5.18.1. NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Nuraleve Inc. Company Overview
    • 5.19.1. Nuraleve Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Soterix Medical Inc Company Overview
    • 5.20.1. Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. St. Jude Medical, Inc. Company Overview
    • 5.21.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. SUNY Downstate Medical Center Company Overview
    • 5.22.1. SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. The University of Utah Company Overview
    • 5.23.1. The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of California, Los Angeles Company Overview
    • 5.24.1. University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. University of Central Florida Company Overview
    • 5.25.1. University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. University of Illinois Company Overview
    • 5.26.1. University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. University of Milan Company Overview
    • 5.27.1. University of Milan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. University of Oxford Company Overview
    • 5.28.1. University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. University of South Florida Company Overview
    • 5.29.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Wedge Therapeutics Company Overview
    • 5.30.1. Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

6. Deep Brain Stimulators- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Deep Brain Stimulators - Pipeline Products by Stage of Development
  • Table 2: Deep Brain Stimulators - Pipeline Products by Territory
  • Table 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path
  • Table 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date
  • Table 5: Deep Brain Stimulators - Ongoing Clinical Trials
  • Table 6: Deep Brain Stimulators Companies - Pipeline Products by Stage of Development
  • Table 7: Deep Brain Stimulators - Pipeline Products by Stage of Development
  • Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: CR-Capable Implant - Product Status
  • Table 10: CR-Capable Implant - Product Description
  • Table 11: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: directSTIM - Product Status
  • Table 13: directSTIM - Product Description
  • Table 14: spiderSTIM - Product Status
  • Table 15: spiderSTIM - Product Description
  • Table 16: Aleva Neurotherapeutics SA - Ongoing Clinical Trials Overview
  • Table 17: directSTIM - Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation Leads for the Treatment of Movement Disorders
  • Table 18: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Directional Lead - Product Status
  • Table 20: Directional Lead - Product Description
  • Table 21: Enspire DBS Therapy System - Stroke - Product Status
  • Table 22: Enspire DBS Therapy System - Stroke - Product Description
  • Table 23: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
  • Table 24: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
  • Table 25: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Status
  • Table 26: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Description
  • Table 27: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 28: Vercise Deep Brain Stimulation System - Parkinson's Disease - Current Steering to Optimize Deep Brain Stimulation
  • Table 29: Vercise Deep Brain Stimulation System - Parkinson's Disease - Implantable Neurostimulator for the Treatment of Parkinson's Disease
  • Table 30: Vercise Deep Brain Stimulation System - Parkinson's Disease - Registry of Deep Brain Stimulation With the VERCISE System: Vercise DBS Registry
  • Table 31: Brainsway Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Deep TMS System - Alzheimer's Disease - Product Status
  • Table 33: Deep TMS System - Alzheimer's Disease - Product Description
  • Table 34: Deep TMS System - Autism - Product Status
  • Table 35: Deep TMS System - Autism - Product Description
  • Table 36: Deep TMS System - Bipolar Disorder - Product Status
  • Table 37: Deep TMS System - Bipolar Disorder - Product Description
  • Table 38: Deep TMS System - MS - Product Status
  • Table 39: Deep TMS System - MS - Product Description
  • Table 40: Deep TMS System - OCD - Product Status
  • Table 41: Deep TMS System - OCD - Product Description
  • Table 42: Deep TMS System - Smoking Cessation - Product Status
  • Table 43: Deep TMS System - Smoking Cessation - Product Description
  • Table 44: Deep TMS System - Stroke - Product Status
  • Table 45: Deep TMS System - Stroke - Product Description
  • Table 46: Brainsway Ltd. - Ongoing Clinical Trials Overview
  • Table 47: Deep TMS System - Bipolar Disorder - Evaluation Clinical, Cognitive and Safety in the Treatment of Bipolar Depression With H1-Coil Deep Transcranial Magnetic Stimulation
  • Table 48: Deep TMS System - Smoking Cessation - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (with the H-ADD Coil) Intended as an Aid to Smoking Cessation
  • Table 49: Deep TMS System - OCD - Tolerability, Safety and Efficacy of the HAC-coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects
  • Table 50: Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Implantable Cooling Therapy Device - Product Status
  • Table 52: Implantable Cooling Therapy Device - Product Description
  • Table 53: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: rTMS H-Coil - Product Status
  • Table 55: rTMS H-Coil - Product Description
  • Table 56: Children's Hospital Boston - Ongoing Clinical Trials Overview
  • Table 57: rTMS H-Coil - Efficacy And Safety Of The H-coil TMS Deep For The Treatment Of Cannabis Addiction
  • Table 58: Cleveland Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: ParkinTune - Product Status
  • Table 60: ParkinTune - Product Description
  • Table 61: Clinatec Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Deep Brain Stimulation Device - Product Status
  • Table 63: Deep Brain Stimulation Device - Product Description
  • Table 64: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: TOPS Device - Alzheimer's Disease - Product Status
  • Table 66: TOPS Device - Alzheimer's Disease - Product Description
  • Table 67: TOPS Device - Depression - Product Status
  • Table 68: TOPS Device - Depression - Product Description
  • Table 69: TOPS Device - Epilepsy - Product Status
  • Table 70: TOPS Device - Epilepsy - Product Description
  • Table 71: TOPS Device - Obesity - Product Status
  • Table 72: TOPS Device - Obesity - Product Description
  • Table 73: TOPS Device - Obsessive-Compulsive Disorder - Product Status
  • Table 74: TOPS Device - Obsessive-Compulsive Disorder - Product Description
  • Table 75: TOPS Device - Parkinson's Disease - Product Status
  • Table 76: TOPS Device - Parkinson's Disease - Product Description
  • Table 77: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: DBS Electrode - Product Status
  • Table 79: DBS Electrode - Product Description
  • Table 80: Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Status
  • Table 82: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Description
  • Table 83: Highland Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: ESStim - Parkinson's Disease - Product Status
  • Table 85: ESStim - Parkinson's Disease - Product Description
  • Table 86: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Deep Brain Stimulation Device - Product Status
  • Table 88: Deep Brain Stimulation Device - Product Description
  • Table 89: Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Sensor System - DBS - Product Status
  • Table 91: Sensor System - DBS - Product Description
  • Table 92: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Status
  • Table 94: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Description
  • Table 95: Reclaim Deep Brain Stimulation System - Depression - Product Status
  • Table 96: Reclaim Deep Brain Stimulation System - Depression - Product Description
  • Table 97: Sapiens DBS Field Steering System - Product Status
  • Table 98: Sapiens DBS Field Steering System - Product Description
  • Table 99: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 100: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Medtronic Registry for Epilepsy (MORE)
  • Table 101: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Responsive Epilepsy Control System-On-Chip - Product Status
  • Table 103: Responsive Epilepsy Control System-On-Chip - Product Description
  • Table 104: NeuroPro Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Deep Brain Stimulation - Product Status
  • Table 106: Deep Brain Stimulation - Product Description
  • Table 107: NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Deep Brain Stimulation System - Cachexia - Product Status
  • Table 109: Deep Brain Stimulation System - Cachexia - Product Description
  • Table 110: Deep Brain Stimulation System - Obesity - Product Status
  • Table 111: Deep Brain Stimulation System - Obesity - Product Description
  • Table 112: Deep Brain Stimulation System - Post-Traumatic Stress Disorder - Product Status
  • Table 113: Deep Brain Stimulation System - Post-Traumatic Stress Disorder - Product Description
  • Table 114: Nuraleve Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: SmartStim M200 Device - Product Status
  • Table 116: SmartStim M200 Device - Product Description
  • Table 117: Nuraleve Inc. - Ongoing Clinical Trials Overview
  • Table 118: SmartStim M200 Device - Pilot Study of Transcranial Direct Current Stimulation (tDCS) as a Smoking Cessation Treatment for Nicotine Dependent Smokers
  • Table 119: Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: HD-tDCS Platform - Product Status
  • Table 121: HD-tDCS Platform - Product Description
  • Table 122: tDCS Device - Product Status
  • Table 123: tDCS Device - Product Description
  • Table 124: Soterix Medical Inc - Ongoing Clinical Trials Overview
  • Table 125: HD-tDCS Platform - A Controlled Trial of Transcranial Direct Current Stimulation as a Treatment for Unipolar and Bipolar Depression
  • Table 126: HD-tDCS Platform - High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
  • Table 127: tDCS Device - Boston-Harvard Burn Injury Model System: Cortical Modulation with Transcranial Direct Current Stimulation (tDCS) for Neuropathic Symptoms Following Burn Injury
  • Table 128: tDCS Device - Effects Of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy On Recovery Of Upper Extremity Motor Function In Stroke Patients
  • Table 129: tDCS Device - Enhancing Cognition in Patients with Late-Life Depression: A Randomized Controlled Trial of Transcranial Direct Current Stimulation
  • Table 130: tDCS Device - Neural Correlates of Pain-related Cognitive Processing in Chronic Pain of the Cornea: An ERP and Electrical Stimulation Study
  • Table 131: tDCS Device - Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation- Induced Modulation of Hyperphagia in Prader-Willi Syndrome
  • Table 132: tDCS Device - Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment
  • Table 133: tDCS Device - Targeted Transcranial Electrotherapy for Stroke Rehabilitation - Exploratory Trial on Aphasia
  • Table 134: tDCS Device - The Effects of tDCS Combined With Balance Training on Postural Control and Spasticity in Chronic Stroke Patients ( A Randomized Controlled Trial)
  • Table 135: tDCS Device - The Influence of tDSC on the Arm and Hand Function in Stroke Patients
  • Table 136: tDCS Device - Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment
  • Table 137: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 138: Infinity DBS System - Product Status
  • Table 139: Infinity DBS System - Product Description
  • Table 140: Libra Deep Brain Stimulation System - Depression - Product Status
  • Table 141: Libra Deep Brain Stimulation System - Depression - Product Description
  • Table 142: Libra Deep Brain Stimulation System - Essential Tremor - Product Status
  • Table 143: Libra Deep Brain Stimulation System - Essential Tremor - Product Description
  • Table 144: Libra Deep Brain Stimulation System - Parkinson's Disease - Product Status
  • Table 145: Libra Deep Brain Stimulation System - Parkinson's Disease - Product Description
  • Table 146: Next Generation Implantable DBS System - Primary Cell - Product Status
  • Table 147: Next Generation Implantable DBS System - Primary Cell - Product Description
  • Table 148: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 149: Libra Deep Brain Stimulation System - Essential Tremor - A Clinical Evaluation of the Advanced Neuromodulation System (ANS) Totally Implantable Deep Brain Stimulation System for the Suppression of Tremor in the Upper Extremities of Patients with Essential Tremor
  • Table 150: Libra Deep Brain Stimulation System - Depression - A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
  • Table 151: Libra Deep Brain Stimulation System - Depression - Deep Brain Stimulation for Treatment-Resistant Depression
  • Table 152: SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 153: Low-Frequency Sine Wave Neurostimulaion Therapy Device - Product Status
  • Table 154: Low-Frequency Sine Wave Neurostimulaion Therapy Device - Product Description
  • Table 155: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • Table 156: DBS10k - Product Status
  • Table 157: DBS10k - Product Description
  • Table 158: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Table 159: Implantable Ultrasound Neuromodulation Device - Product Status
  • Table 160: Implantable Ultrasound Neuromodulation Device - Product Description
  • Table 161: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 162: Deep Brain Stimulation System - Product Status
  • Table 163: Deep Brain Stimulation System - Product Description
  • Table 164: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
  • Table 165: Wireless Deep Brain Stimulation System - Essential Tremor - Product Status
  • Table 166: Wireless Deep Brain Stimulation System - Essential Tremor - Product Description
  • Table 167: Wireless Deep Brain Stimulation System - Parkinson's Disease - Product Status
  • Table 168: Wireless Deep Brain Stimulation System - Parkinson's Disease - Product Description
  • Table 169: University of Milan Pipeline Products & Ongoing Clinical Trials Overview
  • Table 170: Implantable Brain Pacemaker - Product Status
  • Table 171: Implantable Brain Pacemaker - Product Description
  • Table 172: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • Table 173: Adaptive Deep Brain Stimulation System - Product Status
  • Table 174: Adaptive Deep Brain Stimulation System - Product Description
  • Table 175: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 176: Deep Brain Stimulator - Product Status
  • Table 177: Deep Brain Stimulator - Product Description
  • Table 178: Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 179: SONS System - Product Status
  • Table 180: SONS System - Product Description
  • Table 181: Glossary

List of Figures

  • Figure 1: Deep Brain Stimulators - Pipeline Products by Stage of Development
  • Figure 2: Deep Brain Stimulators - Pipeline Products by Territory
  • Figure 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path
  • Figure 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date
  • Figure 5: Deep Brain Stimulators - Ongoing Clinical Trials
Back to Top